Jeffrey William Patterson-Fortin, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA-Directed DNA Polymerase | 4 | 2023 | 489 | 1.550 |
Why?
|
DNA Breaks, Double-Stranded | 7 | 2024 | 612 | 0.890 |
Why?
|
Serum Sickness | 1 | 2016 | 27 | 0.560 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2016 | 33 | 0.550 |
Why?
|
Borrelia burgdorferi Group | 1 | 2016 | 97 | 0.530 |
Why?
|
Receptors, Thrombopoietin | 1 | 2017 | 160 | 0.530 |
Why?
|
Cellulitis | 1 | 2016 | 209 | 0.480 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 560 | 0.460 |
Why?
|
Vision, Low | 1 | 2016 | 163 | 0.460 |
Why?
|
Drug Eruptions | 1 | 2016 | 335 | 0.440 |
Why?
|
Novobiocin | 2 | 2023 | 35 | 0.430 |
Why?
|
Eye Infections, Bacterial | 1 | 2016 | 242 | 0.430 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2024 | 1727 | 0.410 |
Why?
|
Eye | 1 | 2016 | 712 | 0.400 |
Why?
|
Myeloproliferative Disorders | 1 | 2017 | 613 | 0.370 |
Why?
|
Neoplasms | 4 | 2023 | 22170 | 0.340 |
Why?
|
Lyme Disease | 1 | 2016 | 631 | 0.340 |
Why?
|
Pancreatic Neoplasms | 2 | 2024 | 5368 | 0.310 |
Why?
|
Sex Characteristics | 1 | 2017 | 2639 | 0.280 |
Why?
|
Multienzyme Complexes | 1 | 2010 | 666 | 0.280 |
Why?
|
Endopeptidases | 1 | 2010 | 774 | 0.270 |
Why?
|
Cytoplasm | 1 | 2010 | 1510 | 0.250 |
Why?
|
Carrier Proteins | 4 | 2012 | 4936 | 0.240 |
Why?
|
Cell Nucleus | 2 | 2012 | 2909 | 0.240 |
Why?
|
Membrane Proteins | 4 | 2024 | 7856 | 0.210 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2022 | 112 | 0.200 |
Why?
|
Nucleotidyltransferases | 1 | 2024 | 243 | 0.200 |
Why?
|
Nuclear Proteins | 3 | 2010 | 5796 | 0.180 |
Why?
|
Pyridazines | 1 | 2022 | 202 | 0.180 |
Why?
|
Adenosine Triphosphatases | 1 | 2023 | 835 | 0.160 |
Why?
|
Aging | 1 | 2017 | 8708 | 0.150 |
Why?
|
DNA Repair | 2 | 2022 | 2045 | 0.150 |
Why?
|
BRCA1 Protein | 3 | 2024 | 1155 | 0.140 |
Why?
|
Foot Dermatoses | 1 | 2016 | 47 | 0.140 |
Why?
|
Hand Dermatoses | 1 | 2016 | 62 | 0.140 |
Why?
|
Quinazolines | 1 | 2022 | 1371 | 0.130 |
Why?
|
Histone Chaperones | 3 | 2010 | 83 | 0.130 |
Why?
|
Mutation | 2 | 2017 | 30052 | 0.120 |
Why?
|
Glycine Hydroxymethyltransferase | 1 | 2013 | 32 | 0.110 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2013 | 112 | 0.110 |
Why?
|
Pruritus | 1 | 2016 | 380 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4580 | 0.100 |
Why?
|
Arthralgia | 1 | 2016 | 461 | 0.100 |
Why?
|
Catalase | 1 | 2012 | 218 | 0.100 |
Why?
|
DNA Damage | 2 | 2012 | 2446 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2917 | 0.100 |
Why?
|
HeLa Cells | 3 | 2013 | 3093 | 0.090 |
Why?
|
Superoxide Dismutase | 1 | 2012 | 594 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3877 | 0.090 |
Why?
|
Interferons | 1 | 2013 | 706 | 0.080 |
Why?
|
Psoriasis | 1 | 2018 | 950 | 0.080 |
Why?
|
DNA | 1 | 2022 | 7212 | 0.080 |
Why?
|
Ubiquitination | 2 | 2013 | 1006 | 0.080 |
Why?
|
Antirheumatic Agents | 1 | 2018 | 1372 | 0.080 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 200 | 0.080 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4876 | 0.070 |
Why?
|
Humans | 16 | 2024 | 761504 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2010 | 1320 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4352 | 0.070 |
Why?
|
Alleles | 1 | 2017 | 6863 | 0.070 |
Why?
|
DNA-Binding Proteins | 4 | 2012 | 9606 | 0.060 |
Why?
|
Hematologic Neoplasms | 1 | 2017 | 1896 | 0.060 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2018 | 2155 | 0.060 |
Why?
|
Heart Valve Diseases | 1 | 2012 | 1027 | 0.060 |
Why?
|
Calcinosis | 1 | 2012 | 1469 | 0.060 |
Why?
|
Sex Factors | 1 | 2017 | 10552 | 0.050 |
Why?
|
Protein Structure, Tertiary | 1 | 2010 | 3792 | 0.050 |
Why?
|
Aortic Valve | 1 | 2012 | 1955 | 0.050 |
Why?
|
DNA, Single-Stranded | 1 | 2023 | 355 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2012 | 3113 | 0.050 |
Why?
|
Age Factors | 1 | 2017 | 18395 | 0.040 |
Why?
|
Trans-Activators | 1 | 2010 | 2856 | 0.040 |
Why?
|
Cell Cycle | 1 | 2009 | 2932 | 0.040 |
Why?
|
DNA Replication | 1 | 2023 | 1418 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 16981 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2018 | 713 | 0.030 |
Why?
|
Animals | 4 | 2024 | 168459 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2200 | 0.030 |
Why?
|
Female | 6 | 2024 | 392644 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1563 | 0.030 |
Why?
|
Sclerosis | 1 | 2012 | 210 | 0.030 |
Why?
|
Oxidants | 1 | 2012 | 169 | 0.030 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 158 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 3429 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2024 | 3065 | 0.020 |
Why?
|
Ubiquitins | 1 | 2013 | 366 | 0.020 |
Why?
|
Cell Transdifferentiation | 1 | 2012 | 185 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22169 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2016 | 58976 | 0.020 |
Why?
|
Finland | 1 | 2012 | 607 | 0.020 |
Why?
|
Histones | 2 | 2012 | 2580 | 0.020 |
Why?
|
Male | 3 | 2017 | 360804 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2012 | 903 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 588 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2012 | 730 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14414 | 0.020 |
Why?
|
Adenoviridae | 1 | 2012 | 1084 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1171 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2012 | 1738 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1118 | 0.020 |
Why?
|
Mice | 3 | 2024 | 81525 | 0.020 |
Why?
|
Protein Binding | 2 | 2009 | 9351 | 0.020 |
Why?
|
Signal Transduction | 2 | 2024 | 23445 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 1967 | 0.020 |
Why?
|
Osteogenesis | 1 | 2012 | 1273 | 0.020 |
Why?
|
Heterozygote | 1 | 2012 | 2787 | 0.020 |
Why?
|
Transfection | 1 | 2012 | 5774 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2012 | 2141 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21012 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4278 | 0.010 |
Why?
|
Pedigree | 1 | 2012 | 4542 | 0.010 |
Why?
|
Ubiquitin | 1 | 2009 | 839 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2012 | 2455 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2012 | 3395 | 0.010 |
Why?
|
Middle Aged | 1 | 2016 | 220895 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8320 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12441 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13446 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2009 | 1897 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17635 | 0.010 |
Why?
|
Genetic Testing | 1 | 2012 | 3537 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2898 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12795 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2012 | 18965 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16591 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 39967 | 0.010 |
Why?
|
Adult | 2 | 2018 | 221177 | 0.010 |
Why?
|